About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 72834 record(s)
Req # A-2020-000050
Adverse Reaction Report (AER) for DEXLANSOPRAZOLE. Report number: E2B_02969034.Organization: Health Canada
May 2020
Req # A-2020-000054
Adverse Reaction Report (AER) for ULORIC. Report number: 000735448.Organization: Health Canada
May 2020
Req # A-2020-000063
Adverse Reaction Report (AER). Report numbers: E2B_02928614, E2B_02934756, E2B_02951574.Organization: Health Canada
May 2020
Req # A-2020-000084
Adverse Reaction Report (AER). Report number: 000705709.Organization: Health Canada
May 2020
Req # A-2020-000117
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-123505-887, Priorities to Address Aging Information Technology.Organization: Health Canada
May 2020
Req # A-2020-000120
Adverse Reaction Report (AER). Report numbers: 000737101, 000737106.Organization: Health Canada
May 2020
Req # A-2020-000129
Adverse Reaction Report (AER). Report numbers: E2B_02885721, E2B_02891230, E2B_02894317, E2B_02898124, E2B_02898148.Organization: Health Canada
May 2020
Req # A-2020-000205
Adverse Reaction Report (AER) for Cabazitaxel for Injection. Report number: 02487497. ADR for Daptomycin for Injection (350 mg/vial). Report number: 02460009. ADR for Janumet. Report numbers: 02333856, 02333864, 02333872.Organization: Health Canada
May 2020
Req # A-2019-02632
Type, frequency and content (topics covered) of training programs that Members of the Immigration Division of the Immigration and Refugee Board receive with respect to mental health issues in fiscal years 2017-2018, 2018-2019, and 2019-2020.Organization: Immigration and Refugee Board of Canada
May 2020
Req # A-2019-02633
Any policy briefs, internal directives, guidelines, standard operating procedures, protocols, practice manuals, and instructional documentation relating to immigration detainees with mental health issues and vulnerable immigration detainees issued…Organization: Immigration and Refugee Board of Canada
May 2020